What hypofractionated protocols should be tested for prostate cancer?

International Journal of Radiation Oncology Biology Physics

Volumn 56, Issue 4, 2003, Pages 1093-1104

  Fowler, Jack F ^a,d   Ritter, Mark A ^a   Chappell, Rick J ^b   Brenner, David J ^c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c Howard Hughes Medical Institute   (United States)

^d NONE   (United States)

Author keywords

Approximately intermediate risk; Hypofractionation; Prostate tumors; Reduced total doses

Indexed keywords

DISEASE CONTROL; ESTIMATION; RADIOTHERAPY; SENSITIVITY ANALYSIS;

PROSTATE CANCER;

TUMORS;

ARTICLE; BIOCHEMISTRY; CANCER CONTROL; CANCER TEST; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE FRACTIONATION; RECTUM MUCOSA; TREATMENT OUTCOME;

EID: 0038724753     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(03)00132-9     Document Type: Article

References (45)

1. Brenner D.J., Hall E.J. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys. 43:1999;1095-1101.
2. Haustermans K., Fowler J.F. A comment on proliferation rates in human prostate cancer. Int J Radiat Oncol Biol Phys. 48:2000;297. [Letter].
3. King C.R., Mayo C.S. Is the prostate α/β ratio of 1 5 from Brenner and Hall a modeling artifact? Int J Radiat Oncol Biol Phys. 47:2000;536-538.
4. Brenner D.J., Hall E.J. In response to Drs King and Mayo Low α/β values for prostate appear to be independent of modeling details . Int J Radiat Oncol Biol Phys. 47:2000;538-539.
5. King C.T., Fowler J.F. A simple analytic derivation suggests that prostate cancer α/β ratio is low. Int J Radiat Oncol Biol Phys. 51:2001;213-214. [Letter].
6. Fowler J.F., Chappell R.J., Ritter M.A. Is the α/β ratio for prostate tumors really low? Int J Radiat Oncol Biol Phys. 50:2001;1021-1031.
7. Dale RG, Jones B. Is the α/β for prostate tumors really low? In regard to Fowler [RBE in] Fowler et al., IJROBP 2001;50:1021-1031. See also reply: Letter to the Editor. Int J Radiat Oncol Biol Phys 2002;52:1427-1428.
8. Brenner D.J., Martinez A.A., Edmundson G.K., Mitchell C., Thames H.D., Armour E.P. Direct evidence that prostate tumors show high sensitivity to fractionation (low α/β ratio) comparable to late-responding normal tissue. Int J Radiat Oncol Biol Phys. 52:2002;6-13.
9. Kupelian P.A., Reddy C.A., Carlson T.P., et al. Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy/fraction) for localized prostate cancer. Int J Radiat Oncol Biol Phys. 53:2002;904-912.
10. Reuther A.M., Willoughby T.R., Kupelian P.A. Toxicity after hypofractionated external beam radiotherapy (70 Gy at 2.5 Gy per fraction) versus standard fractionation radiotherapy (78 Gy at 2.0. Gy per fraction) for localized prostate cancer. Abstract # 1050. Int J Radiat Oncol Biol Phys. 54:(Suppl. 2):2002;187-188.
11. Brenner D.J. Towards optimal external-beam fractionation for prostate cancer. Int J Radiat Oncol Biol Phys. 48:2000;315-316. [Editorial].
12. Fowler J.F., Chappell R., Ritter M.A. The prospects for new treatments for prostate cancer. Int J Radiat Oncol Biol Phys. 52:2002;3-5. [Editorial].
13. Fowler J.F. Review article The linear-quadratic formula and progress in fractionated radiotherapy . Br J Radiol. 62:1989;679-694.
14. Leborgne F., Fowler J.F., Leborgne J.H., Zubizarreta E., Chappell R. Fractionation in medium dose rate brachytherapy of cancer of the cervix. Int J Radiat Oncol Biol Phys. 35:1996;907-914.
15. Leborgne F., Fowler J.F., Leborgne J.H., Zubizaretta E., Chappell R. Biologically effective doses in medium dose-rate brachytherapy of cancer of the cervix. Rad Onc Invest. 5:1997;289-299.
16. Brenner D.J., Armour E., Corry P., Hall E. Sublethal damage repair times for a late-responding normal tissue relevant to brachytherapy (and external-beam radiotherapy) Implications for new brachytherapy protocols . Int J Radiat Oncol Biol Phys. 41:1998;135-138.
17. Dubray M.B., Thames H.D. Chronic radiation damage in the rat rectum An analysis of the influences of fractionation, time and volume . Radiother Oncol. 33:1994;41-47.
18. Stokes SH. Comparison of biochemical disease-free survival of patients with localized carcinoma of the prostate undergoing radical prostatectomy, transperineal ultrasound-guided radioactive seed implantation, or definitive external beam irradiation. Int J Radiat Oncol Biol Phys. 47:2000;129-136.
19. Hanks G.E., Hanlon A.L., Pinover W.H., Horwitz E.M., Price R.A., Schultheiss T. Dose selection for prostate cancer patients based on dose comparison and dose response studies. Int J Radiat Oncol Biol Phys. 46:2000;823-832.
20. Vicini F., Kestin L., Martinez A.A. The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancer. Int J Radiat Oncol Biol Phys. 45:1999;553-561.
21. Zelefsky M.J., Leibel S.A., Gaudin P.B., et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys. 41:1998;491-500.
22. Pollack A., Zagars G.K., Smith L.G., Antolak J.A., Rosen I.I. Preliminary results of a randomized dose-escalation study comparing 70 Gy to 78 Gy for the treatment of prostate cancer (Abstr). Int J Radiat Oncol Biol Phys. 45:(Suppl):1999;146-147.
23. Pollack A., Smith L.G., von Eschenbach A.C. External beam radiotherapy dose response characteristics of 1127 men with prostate cancer treated in the PSA era. Int J Radiat Oncol Biol Phys. 45:(Suppl.):1999;507-512.
24. Shipley W.U., Thames H.D., Sandler J.M., et al. Radiation therapy for clinically localized prostate cancer A multi-institutional pooled analysis . JAMA. 281:1999;1598-1604.
25. Yaes R.J., Patel P., Maruyama Y. On using the linear-quadratic model in daily clinical practice. Int J Radiat Oncol Biol Phys. 20:1991;1353-1362.
26. Lebesque J.V., Keus R.B. The simultaneous boost technique The concept of relative normalized total dose . Radiother Oncol. 22:1991;45-55.
27. Schwarchuk M.W., Jackson A., Zelefsky M.J., et al. Late rectal toxicity after conformal radiotherapy of prostate cancer (I) Multivariate analysis and dose-response . Int J Radiat Oncol Biol Phys. 47:2000;103-113.
28. Huang E., Pollack A., Levy L., et al. Late rectal toxicity Dose-volume effects of conformal radiotherapy for prostate cancer . Int J Radiat Oncol Biol Phys. 54:2002;1314-1321.
29. Kupelian P.A., Reddy C.A., Carlson T.P. Dose/volume relationship of late rectal bleeding after external beam radiotherapy for localized prostate cancer Absolute or relative rectal volume? Cancer Journal from American Express. 8:2002;62-66.
30. Brenner D.J., Hlatky L.R., Hahnfeld P.J., et al. The Linear-Quadratic model, and most other common radiobiological models result in similar predictions for time-dose relationships. Radiat Res. 150:1998;1-9.
31. Bartkowiak D., Hogner S., Nothdurft W., et al. Cell cycle and growth response of CHO cells to X-irradiation Threshold-free repair at low doses . Int J Radiat Oncol Biol Phys. 50:2001;221-228.
32. Kummermehr J., Malinen E., Freykowski S., et al. The influence of autologous tumor fibroblasts on the radiosensitivity of squamous cell carcinoma megacolonies. Int J Radiat Oncol Biol Phys. 50:2001;229-237.
33. Wang J.Z., Guerrero M., Allen Li X. How low is the α/β ratio for prostate cancer? Int J Radiat Oncol Biol Phys. 55:2003;194-203.
34. Withers H.R., Taylor J.M.G., Maciejewski B. The hazard of accelerated clonogen repopulation during radiotherapy. Acta Oncol. 27:1988;131-146.
35. Brenner D.J. Accelerated repopulation during radiotherapy; quantitative evidence for delayed onset. Radiat Oncol Invest. 1:1993;167-172.
36. Roberts S.A., Hendry J.H. The delay before onset of accelerated tumor cell repopulation during radiotherapy A direct-maximum likelihood analysis of a collection of world-wide tumor-control data . Radiother Oncol. 29:1993;69-74.
37. van der Kogel A.J., Jarrett K.A., Paciotti M.A., Raju M.R. Radiation tolerance of the rat rectum to fractionated X-rays and pi-mesons. Radiother Oncol. 12:1988;225-232.
38. Dewit L., Oussoren Y., Bartelink H., Thames H.D. The effect of cis-diamminedichloroplatinum(II) on radiation damage in mouse rectum after fractionated irradiation. Radiother Oncol. 16:1989;121-128.
39. Terry N.A.H., Denekamp J. RBE values and repair characteristics for colorectal injury after caesium 137 gamma ray and neutron irradiation. II Fractionation up to ten doses. Br J Radiol. 57:1984;617-629.
40. Gasinska A., Dubray B., Hill S.A., Denekamp J., Thames H.D. Early and late injuries in mouse rectum after fractionated x-ray and neutron irradiation. Radiother Oncol. 26:1993;244-253.
41. Jereczek-Fossa B.A., Jassem J., Badzio A. Relationship between acute and late normal tissue injury after postoperative radiotherapy in endometrial cancer. Int J Radiat Oncol Biol Phys. 52:2002;476-482.
42. Leung S.W., et al. The corrrelation of acute toxicity and late rectal injury in radiotherapy for cervical carcinoma Evidence suggestive of consequential late effect (CQLE) . Int J Radiat Oncol Biol Phys. 40:1998;85-91.
43. Dörr W., Hendry J.H. Consequential late effects in normal tissues (Review). Radiother Oncol. 61:2001;223-231.
44. Mohan D.S., Kupelian P.A., Willoughby T.R. Short-course intensity-modulated radiotherapy for localized prostate cancer with daily transabdominal ultrasound localization of the prostate gland. Int J Radiat Oncol Biol Phys. 46:2000;575-580.
45. Logue J.P., Livsey J.E., Cowan R.A., et al. Hypofractionated conformal radiotherapy of the prostate 5-year outcome analysis . Int J Radiat Oncol Biol Phys. 54:(2S):2002;189. [Abstract 1052].